Parameters of Mycoplasma pneumoniae infection in Syrian hamsters
- PMID: 3137169
- PMCID: PMC259586
- DOI: 10.1128/iai.56.9.2443-2449.1988
Parameters of Mycoplasma pneumoniae infection in Syrian hamsters
Abstract
An animal model for evaluating the potency of Mycoplasma pneumoniae vaccines was developed with hamsters. Factors that influence hamster infection by M. pneumoniae were defined, and parameters for assessment of intensity of pulmonary disease were established. Colonization of hamster lungs was determined by culture, and intensity of lung disease was assessed histopathologically and expressed numerically as a lung pathological score. Intratracheal inoculation of the challenge was superior to the intranasal or aerosol route for inducing a consistent degree of lung disease. A challenge dose of 10(6) CFU inoculated intratracheally produced lung colonization and significant reproducible lung pathological scores in essentially all unvaccinated animals. The peak of infection, as determined by these criteria, was at about 2 weeks after challenge. Animals over 6 weeks of age were preferable for the test, since younger animals exhibited a lower lung pathological score even though they showed the same degree of lung colonization. The hamster assay developed provides a dependable experimental system for testing the protective potency of M. pneumoniae vaccines.
Similar articles
-
Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines.Infect Immun. 1988 Sep;56(9):2450-7. doi: 10.1128/iai.56.9.2450-2457.1988. Infect Immun. 1988. PMID: 3137170 Free PMC article.
-
Effect of oxytetracycline and erythromycin on Syrian hamsters after intratracheal infection with Mycoplasma pneumoniae.J Hyg Epidemiol Microbiol Immunol. 1987;31(1):83-9. J Hyg Epidemiol Microbiol Immunol. 1987. PMID: 3106470
-
Effects of new quinolones on Mycoplasma pneumoniae-infected hamsters.Antimicrob Agents Chemother. 1993 Feb;37(2):287-92. doi: 10.1128/AAC.37.2.287. Antimicrob Agents Chemother. 1993. PMID: 8383942 Free PMC article.
-
[Imaging diagnosis of Mycoplasma pneumoniae pneumonia].Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:240-6. Nihon Rinsho. 2007. PMID: 17455624 Review. Japanese. No abstract available.
-
[Pathogenicity factors of Mycoplasma pneumoniae].Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1989 Jan-Mar;34(1):67-74. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1989. PMID: 2506624 Review. Romanian. No abstract available.
Cited by
-
Analysis of three different repeated DNA elements present in the P1 operon of Mycoplasma pneumoniae: size, number and distribution on the genome.Nucleic Acids Res. 1990 Nov 11;18(21):6311-7. doi: 10.1093/nar/18.21.6311. Nucleic Acids Res. 1990. PMID: 2123027 Free PMC article.
-
Immunoblot analyses of chimpanzee sera after infection and after immunization and challenge with Mycoplasma pneumoniae.Infect Immun. 1994 Mar;62(3):1008-14. doi: 10.1128/iai.62.3.1008-1014.1994. Infect Immun. 1994. PMID: 8112834 Free PMC article.
-
Genotyping of Mycoplasma pneumoniae strains isolated in Japan during 2019 and 2020: spread of p1 gene type 2c and 2j variant strains.Front Microbiol. 2023 Jun 19;14:1202357. doi: 10.3389/fmicb.2023.1202357. eCollection 2023. Front Microbiol. 2023. PMID: 37405159 Free PMC article.
-
Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines.Infect Immun. 1988 Sep;56(9):2450-7. doi: 10.1128/iai.56.9.2450-2457.1988. Infect Immun. 1988. PMID: 3137170 Free PMC article.
-
The immunodominant 90-kilodalton protein is localized on the terminal tip structure of Mycoplasma pneumoniae.Infect Immun. 1993 Apr;61(4):1523-30. doi: 10.1128/iai.61.4.1523-1530.1993. Infect Immun. 1993. PMID: 8454358 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources